X Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation», 4-5 April 2016, Nizhny Novgorod

Bashlakova E.E., Evdoshenko E.P., Polyakova K.I., Skoromets A.A., Solodun I.Y., Fisun A.G., Holownia M.A. 7222

Budget impact analysis of the inclusion of teriflunomid in the program «7 high cost diseases» on the budget of the federal and regional authorities of the Russian Federation in the field of health care for patients with multiple sclerosis

Reshetko O.V., Yakimova Y.N. 8115

Pharmacists actions in antibiotics sales

Miroshnichenko Y.V., Scherba M.P. 6474

Cost analysis of antidiabetic drugs in the health care delivery attached to the military medical organizations diabetic patients in outpatient settings

Ardenova N.N., Rizhenkova I.G., Chernaya E.V. 6436

Insulinotherapy of diabetes mellitus in patients with hypertension

Burbello A.T., Gaykovaja L.B., Zagorodnikova K.A., Kosticina M.A., Pokladova M.V., Fedorenko A.S. 6426

Possibilities of сliniсo-eсonomiс analysis in work of clinical pharmacologist

Ugrekhelidze D.T. 6098

Pharmacoeconomic study of the use of botulinum toxin type A in the treatment of spastic forms of cerebral palsy in Moscow region

Ardenova N.N., Reshetko O.V., Rykalina E.B., Sokolov A.V., Furman N.V. 6545

Pharmacotherapy of heart insufficiency in hospital

Krasilnikov D.M., Safiullin M.R., Shakirova D.H. 6192

Analysis of hospital costs of antibiotic therapy in patients with destructive pancreatitis

Strunina (Rybchenko) Y.V. 6582

Using pharmacoeconomic analysis of the Russian Federation

Pochuprina A.A. 6209

The relevance of cost of illness analysis of systemic lupus erythematosus from perspective health care system of Russian Federation

Ponomareva A.A. 6469

Aapplication of pharmacoeconomic methods for the selection of the optimal scheme of anti-microbial therapy of pyelonephritis in children

Nosova P.S., Reshetko O.V. 6396

Pharmacoepidemiologic analysis of antipsychotic adverse effects in schizophrenia in different hospitals

Makarova E.I. 6564

Features of pharmacoeconomic evaluation of the application of inhaled drugs with modern delivery devices in patients with bronchial asthma

Levitan A.I., Reshetko O.V. 6664

Adherence to drug therapy on rheumatoid arthritis

Baytman T.P., Ivlichev A.V., Levitan A.I., Reshetko O.V. 6165

Pharmacoepidemiologic analysis of peptic ulcer pharmacotherapy in Saratov gastroenterologic department

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 6440

Comparative clinical and economic analysis of the outcomes of type 2 diabetes mellitus (T2DM) treated with insulin glargin or insulin degludec in combination with oral antidiabetic agents (OAD)

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 6495

Comparative clinical and economic analysis of the outcomes of type 2 diabetes mellitus (T2DM) treated with insulin glargin or insulin degludec as part of basal-bolus therapy

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 6439

Comparative clinical and economic analysis of the outcomes of type 1 diabetes mellitus (T1DM) treated with insulin glargin or insulin degludec as part of basal-bolus therapy

Zhukova O.V. 6699

Fishburnes method, Monte Carlo simulation and the classical method of pharmacoeconomic analysis in the evaluation of antibiotic treatment of acute bronchitis with bronchospasm in children

Dolotovskaya P.V., Malinova L.I., Reshetko O.V., Furman N.V. 6482

Pharmacoepidemiology of P2Y12 receptors blockers in acute coronary syndrome with ST elevation in real clinical practice

Dolotovskaya P.V., Malinova L.I., Reshetko O.V., Furman N.V. 6668

Ratio “cost-effectiveness” for clopidogrel and tikagrelor in acute coronary syndrome with ST elevation in real clinical practice

Gorbatenko V.S., Maslakov A.S., Shatalova O.V. 6375

Retail sales monitoring of oral anticoagulants in Volgograd

Abdrashitova G.T. 6188

X Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation»
4-5 April 2016 year, Nizhny Novgorod